Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Trial Phase 2 Completed Dec. 22, 2020

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Trial Phase 2 Completed Dec. 22, 2020

Vibration Impact on Parkinson's Tremor

Trial N/A Completed Dec. 16, 2020

Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain

Trial Early Phase 1 Completed Dec. 13, 2020

Oxford Study of Quantification in Parkinsonism

Trial N/A Unknown Dec. 10, 2020

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

Trial N/A Completed Dec. 8, 2020

Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)

Trial Phase 1 Terminated Dec. 8, 2020

PK Study in Patients With Parkinson's Disease With IZD174

Trial Phase 1 Withdrawn Dec. 3, 2020

Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease

Trial N/A Completed Dec. 2, 2020

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

Trial N/A Completed Dec. 1, 2020

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

Trial Phase 2 Completed Nov. 30, 2020

MER Versus MRI Guidance DBS in Parkinson's Disease

Trial N/A Completed Nov. 24, 2020

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Trial Phase 2 Terminated Nov. 22, 2020

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Trial Phase 2 Terminated Nov. 22, 2020

An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients

Trial Phase 2 Completed Nov. 22, 2020

Non Invasive Neuromodulation for Patients With Motor Control Disorders

Trial N/A Completed Nov. 19, 2020

Repetitive Transcranial Magnetic Stimulation With H-coil in Parkinson's Disease (rTMS-PD)

Trial N/A Completed Nov. 19, 2020

Goal Management Training for Parkinson Disease Mild Cognitive Impairment

Trial N/A Completed Nov. 18, 2020

Safety and Efficacy of Adaptive DBS Vs Conventional DBS in Patients With Parkinson's Disease

Trial N/A Terminated Nov. 18, 2020